摘要
目的探讨降钙素原(PCT)检测在慢性阻塞性肺疾病患者急性加重期的临床意义。方法入选87例慢性阻塞性肺疾病患者,其中18例稳定期患者作为稳定组,69例急性期患者分为单纯组(22例)和肺炎组(47例)。对患者的白细胞计数、PCT、痰培养结果、住院时间等进行分析比较。结果肺炎组患者住院时间和白细胞计数高于单纯组,差异有统计学意义(P<0.05)。3组PCT水平比较,差异有统计学意义(P<0.05),肺炎组最高,稳定组最低。结论血清PCT能反映慢性阻塞性肺疾病不同时期炎症程度,指导临床治疗。
Objective To evaluate the clinical significance of procalcitonin（PCT） in patients of acute exacerbation of chronic obstructive pulmonary disease（COPD）.Methods 87 patients with COPD,including 18 cases of patients with stable as the stable group,69 cases of acute period were divided into control group（22 cases） and pneumonia group（47 cases）.The white blood cell（WBC）,PCT,and microbiological findings in each group were compared.Results Pneumonia and white blood cell count in patients was significantly higher than control group,the difference was statistically significant（P〈0.05）.Comparison of level of PCT in the 3 groups,the difference was statistically significant（P〈0.05）,pneumonia group was the highest,stable group was the lowest.Conclusion PCT level is valuable to differentiate the clinical status of COPD,and guide its treatment.
出处
《实用心脑肺血管病杂志》
2013年第6期20-21,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
降钙素原
肺疾病
慢性阻塞性
肺炎
Procalcitonin
Pulmonary disease
chronic obstructive
Pneumonia
